IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report
- PMID: 33930555
- PMCID: PMC8079259
- DOI: 10.1016/j.clim.2021.108743
IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report
Figures
Comment on
-
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.Clin Immunol. 2021 May;226:108699. doi: 10.1016/j.clim.2021.108699. Epub 2021 Feb 25. Clin Immunol. 2021. PMID: 33639276 Free PMC article. Review.
References
-
- Tonduti D., Fazzi E., Badolato R., Orcesi S. Novel and emerging treatments for Aicardi-Goutières syndrome. Expert Rev Clin Immunol. 2020;16(2) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous